A study to determine effects of esketamine on emotion processing and cognitive functioning, both acutely and sub-chronically
Latest Information Update: 04 Feb 2025
Price :
$35 *
At a glance
- Drugs Esketamine (Primary)
- Indications Bipolar depression; Depression; Depressive disorders
- Focus Therapeutic Use
- 04 Feb 2025 New trial record
- 01 Jan 2025 Results published in the World Journal of Biological Psychiatry
- 01 Jan 2025 According to Results published in the Media Release, study was supported by the DYNAMIC centre, funded by the LOEWE program of the Hessian Ministry of Science and Art.